Boston Scientific (BSX) to Acquire Bolt Medical
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Deutsche Bank Upgrades Boston Scientific (BSX) to Buy
January 10, 2025 7:08 AM ESTDeutsche Bank analyst Pito Chickering upgraded Boston Scientific (NYSE: BSX) from Hold to Buy with a price target of $108.00 (from $87.00).
The analyst comments "So the BSX story has become simpler, and as one of the best-in-class medtech names, we believe BSX is poised again to outperform in 2025, and we are upgrading the shares to Buy with a $108 price target which is 34x our 2026E EPS. There are many risks to our Buy thesis: (1) BSX is one of the most consensus longs within our coverage universe. So who might be the... More
